| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | total anomalous pulmonary venous connection, intracardiac | 2.13e-05 | 2 | 65 | 2 | MP:0010443 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF469 ZNF527 ZNF672 ZNF497 ZNF608 KLF6 MZF1 ZNF559 ZNF423 ZFP64 KCMF1 ZNF407 ZNF324B ZNF467 | 1.69e-05 | 775 | 89 | 14 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF469 ZNF527 ZNF672 ZNF497 ZNF608 KLF6 MZF1 ZNF559 ZNF423 ZFP64 KCMF1 ZNF407 ZNF324B ZNF467 | 1.74e-05 | 777 | 89 | 14 | PS00028 |
| Domain | ARHGEF5_35 | 2.25e-05 | 2 | 89 | 2 | PF15441 | |
| Domain | Tis11B_N | 2.25e-05 | 2 | 89 | 2 | PF04553 | |
| Domain | ARHGEF5/35_N | 2.25e-05 | 2 | 89 | 2 | IPR029212 | |
| Domain | Tis11B_N | 2.25e-05 | 2 | 89 | 2 | IPR007635 | |
| Domain | Znf_C2H2-like | ZNF469 ZNF527 ZNF672 ZNF497 ZNF608 KLF6 MZF1 ZNF559 ZNF423 ZFP64 KCMF1 ZNF407 ZNF324B ZNF467 | 2.28e-05 | 796 | 89 | 14 | IPR015880 |
| Domain | Znf_C2H2 | ZNF469 ZNF527 ZNF672 ZNF497 ZNF608 KLF6 MZF1 ZNF559 ZNF423 ZFP64 KCMF1 ZNF407 ZNF324B ZNF467 | 2.58e-05 | 805 | 89 | 14 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF469 ZNF527 ZNF672 ZNF497 ZNF608 KLF6 MZF1 ZNF559 ZNF423 ZFP64 KCMF1 ZNF407 ZNF324B ZNF467 | 2.69e-05 | 808 | 89 | 14 | SM00355 |
| Domain | CFC | 6.72e-05 | 3 | 89 | 2 | PF09443 | |
| Domain | Cryptic/Cripto_CFC-dom | 6.72e-05 | 3 | 89 | 2 | IPR019011 | |
| Domain | LCE | 6.78e-05 | 17 | 89 | 3 | PF14672 | |
| Domain | LCE | 6.78e-05 | 17 | 89 | 3 | IPR028205 | |
| Domain | zf-C2H2 | ZNF469 ZNF527 ZNF672 ZNF497 KLF6 MZF1 ZNF559 ZNF423 ZFP64 ZNF407 ZNF324B ZNF467 | 1.07e-04 | 693 | 89 | 12 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF469 ZNF527 ZNF672 ZNF497 KLF6 MZF1 ZNF559 ZNF423 ZFP64 ZNF407 ZNF324B ZNF467 | 1.09e-04 | 694 | 89 | 12 | IPR013087 |
| Domain | SPRR/LCE | 3.14e-04 | 28 | 89 | 3 | IPR026075 | |
| Domain | - | ZNF527 ZNF672 ZNF497 KLF6 MZF1 ZNF559 ZNF423 ZFP64 ZNF407 ZNF324B ZNF467 | 3.75e-04 | 679 | 89 | 11 | 3.30.160.60 |
| Domain | zf-C2H2_6 | 7.53e-04 | 314 | 89 | 7 | PF13912 | |
| Domain | PH_dom-spectrin-type | 7.91e-04 | 9 | 89 | 2 | IPR001605 | |
| Domain | PH | 4.78e-03 | 229 | 89 | 5 | PF00169 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 21737615 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 20622884 | ||
| Pubmed | Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase. | 6.92e-06 | 2 | 92 | 2 | 10777567 | |
| Pubmed | The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer. | 6.92e-06 | 2 | 92 | 2 | 11174844 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 22367205 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 23048070 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 11327798 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 11024280 | ||
| Pubmed | ZFP36L1 and ZFP36L2 inhibit cell proliferation in a cyclin D-dependent and p53-independent manner. | 6.92e-06 | 2 | 92 | 2 | 29426877 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 32311426 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 11062482 | ||
| Pubmed | 9.78e-06 | 16 | 92 | 3 | 17410201 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 27624101 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 14604009 | ||
| Pubmed | Conserved regulation and role of Pitx2 in situs-specific morphogenesis of visceral organs. | 2.07e-05 | 3 | 92 | 2 | 16835440 | |
| Pubmed | The RNA-binding proteins Zfp36l1 and Zfp36l2 act redundantly in myogenesis. | 2.07e-05 | 3 | 92 | 2 | 30526691 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 27566829 | ||
| Pubmed | ZFP36 Family Members Regulate the Proinflammatory Features of Psoriatic Dermal Fibroblasts. | 2.07e-05 | 3 | 92 | 2 | 34333017 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 27182009 | ||
| Pubmed | The ZFP36 family of RNA binding proteins regulates homeostatic and autoreactive T cell responses. | 2.07e-05 | 3 | 92 | 2 | 36269839 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 21278925 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 15814898 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 1996120 | ||
| Pubmed | 2.66e-05 | 22 | 92 | 3 | 15854049 | ||
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | 3.05e-05 | 23 | 92 | 3 | 11698679 | |
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 37169211 | ||
| Pubmed | Synergistic roles of tristetraprolin family members in myeloid cells in the control of inflammation. | 4.14e-05 | 4 | 92 | 2 | 37903626 | |
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 12082611 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 20166898 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 11418237 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 11796723 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 11825688 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 35042959 | ||
| Pubmed | ZFP36L1 and ZFP36L2 control LDLR mRNA stability via the ERK-RSK pathway. | 4.14e-05 | 4 | 92 | 2 | 25106868 | |
| Pubmed | Specific arrest of cardiogenesis in cultured embryonic stem cells lacking Cripto-1. | 4.14e-05 | 4 | 92 | 2 | 9576836 | |
| Pubmed | RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence. | 4.14e-05 | 4 | 92 | 2 | 27102483 | |
| Pubmed | Role of the EGF-CFC gene cripto in cell differentiation and embryo development. | 4.14e-05 | 4 | 92 | 2 | 11992720 | |
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 36795484 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 22701344 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 38157296 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 24733888 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 26952984 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 9053319 | ||
| Pubmed | Self-regulated left-right asymmetric expression of Pitx2c in the developing mouse limb. | 6.89e-05 | 5 | 92 | 2 | 25224222 | |
| Pubmed | Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. | 6.89e-05 | 5 | 92 | 2 | 15467755 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TGFB1I1 ZFP36L1 ZFP36L2 JADE3 KCMF1 AP1G2 TNKS SSH2 DOCK6 KANK2 CNOT1 | 9.41e-05 | 1038 | 92 | 11 | 26673895 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PLEKHG1 ESYT2 ABL1 NCKAP1 ZFP36L1 ZFP36L2 ARHGEF5 SSH2 DOCK6 PLEKHA7 | 9.49e-05 | 861 | 92 | 10 | 36931259 |
| Pubmed | A role of the cryptic gene in the correct establishment of the left-right axis. | 1.03e-04 | 6 | 92 | 2 | 10574770 | |
| Pubmed | Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway. | 1.03e-04 | 6 | 92 | 2 | 12052855 | |
| Pubmed | 1.03e-04 | 6 | 92 | 2 | 28394372 | ||
| Pubmed | 1.03e-04 | 6 | 92 | 2 | 17991893 | ||
| Pubmed | 1.03e-04 | 6 | 92 | 2 | 8756350 | ||
| Pubmed | Conserved requirement for EGF-CFC genes in vertebrate left-right axis formation. | 1.44e-04 | 7 | 92 | 2 | 10521397 | |
| Pubmed | Reversal of left-right asymmetry induced by aberrant Nodal signaling in the node of mouse embryos. | 1.44e-04 | 7 | 92 | 2 | 19906859 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.49e-04 | 430 | 92 | 7 | 35044719 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PPP1R26 CPTP PLEKHG1 ABL1 ZFP36L2 AP1G2 TOR4A GRIN2D ZNF324B DOCK6 TRIM7 | 1.63e-04 | 1105 | 92 | 11 | 35748872 |
| Pubmed | 1.92e-04 | 8 | 92 | 2 | 11475331 | ||
| Pubmed | 1.92e-04 | 8 | 92 | 2 | 21419113 | ||
| Pubmed | Two nodal-responsive enhancers control left-right asymmetric expression of Nodal. | 1.92e-04 | 8 | 92 | 2 | 15736223 | |
| Pubmed | Left-right patterning of the mouse lateral plate requires nodal produced in the node. | 2.46e-04 | 9 | 92 | 2 | 12654299 | |
| Pubmed | 2.46e-04 | 9 | 92 | 2 | 18773496 | ||
| Pubmed | 3.07e-04 | 10 | 92 | 2 | 17913787 | ||
| Pubmed | Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway. | 3.75e-04 | 11 | 92 | 2 | 15475956 | |
| Pubmed | 5.30e-04 | 13 | 92 | 2 | 18550712 | ||
| Pubmed | 6.17e-04 | 14 | 92 | 2 | 15749123 | ||
| Pubmed | Genetic mapping of the mouse genes encoding the voltage-sensitive calcium channel subunits. | 6.17e-04 | 14 | 92 | 2 | 7490102 | |
| Pubmed | 6.17e-04 | 14 | 92 | 2 | 25852085 | ||
| Pubmed | 6.17e-04 | 14 | 92 | 2 | 17210915 | ||
| Pubmed | 7.11e-04 | 15 | 92 | 2 | 20188150 | ||
| Pubmed | 7.11e-04 | 15 | 92 | 2 | 24453333 | ||
| Pubmed | 7.11e-04 | 15 | 92 | 2 | 12361961 | ||
| Pubmed | 7.11e-04 | 15 | 92 | 2 | 24780629 | ||
| Pubmed | 7.11e-04 | 15 | 92 | 2 | 33730615 | ||
| Pubmed | Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cells. | 7.11e-04 | 15 | 92 | 2 | 17360443 | |
| Pubmed | 9.17e-04 | 17 | 92 | 2 | 18697220 | ||
| Pubmed | 9.17e-04 | 17 | 92 | 2 | 19716815 | ||
| Pubmed | 9.17e-04 | 17 | 92 | 2 | 22627279 | ||
| Pubmed | 1.03e-03 | 963 | 92 | 9 | 28671696 | ||
| Pubmed | 1.03e-03 | 18 | 92 | 2 | 17936261 | ||
| Pubmed | Gene structure and chromosomal localization of the mouse NMDA receptor channel subunits. | 1.03e-03 | 18 | 92 | 2 | 9011744 | |
| Pubmed | Tcf3: a transcriptional regulator of axis induction in the early embryo. | 1.03e-03 | 18 | 92 | 2 | 14668413 | |
| Pubmed | 1.03e-03 | 18 | 92 | 2 | 20346354 | ||
| Pubmed | 1.15e-03 | 19 | 92 | 2 | 22675492 | ||
| Pubmed | 1.15e-03 | 19 | 92 | 2 | 28126904 | ||
| Pubmed | 1.21e-03 | 446 | 92 | 6 | 24255178 | ||
| Pubmed | 1.27e-03 | 20 | 92 | 2 | 11517919 | ||
| Pubmed | 1.27e-03 | 20 | 92 | 2 | 11440720 | ||
| Pubmed | Loss-of-Function Variants in TBC1D32 Underlie Syndromic Hypopituitarism. | 1.32e-03 | 81 | 92 | 3 | 32060556 | |
| Pubmed | Wnt3a links left-right determination with segmentation and anteroposterior axis elongation. | 1.41e-03 | 21 | 92 | 2 | 16291790 | |
| Pubmed | Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo. | 1.54e-03 | 22 | 92 | 2 | 18241853 | |
| Pubmed | 1.54e-03 | 22 | 92 | 2 | 33903225 | ||
| Pubmed | 1.69e-03 | 23 | 92 | 2 | 20932654 | ||
| Pubmed | 1.69e-03 | 23 | 92 | 2 | 14623818 | ||
| Pubmed | 1.84e-03 | 24 | 92 | 2 | 18171685 | ||
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 1.90e-03 | 331 | 92 | 5 | 19490893 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 1.93e-03 | 853 | 92 | 8 | 28718761 | |
| Pubmed | 2.07e-03 | 496 | 92 | 6 | 31343991 | ||
| Pubmed | Endogenous Nodal signaling regulates germ cell potency during mammalian testis development. | 2.16e-03 | 26 | 92 | 2 | 23034635 | |
| Pubmed | The T-box transcription factor Eomesodermin is essential for AVE induction in the mouse embryo. | 2.16e-03 | 26 | 92 | 2 | 23651855 | |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 2.41e-03 | 100 | 92 | 3 | 25807483 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 5.14e-05 | 325 | 92 | 6 | chr9q34 | |
| Cytoband | 9q34.3 | 6.42e-05 | 106 | 92 | 4 | 9q34.3 | |
| Cytoband | 19p13.2 | 1.02e-04 | 229 | 92 | 5 | 19p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.13e-03 | 797 | 92 | 7 | chr19p13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF469 ZNF527 ZNF672 ZNF497 ZNF608 KLF6 MZF1 ZNF559 ZNF423 ZFP64 ZNF407 ZNF324B ZNF467 | 7.54e-07 | 718 | 62 | 13 | 28 |
| GeneFamily | Late cornified envelope proteins | 3.02e-05 | 18 | 62 | 3 | 627 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.51e-03 | 66 | 62 | 3 | 722 | |
| GeneFamily | Ring finger proteins | 2.51e-03 | 275 | 62 | 5 | 58 | |
| GeneFamily | Sterile alpha motif domain containing | 3.43e-03 | 88 | 62 | 3 | 760 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.57e-03 | 26 | 62 | 2 | 253 | |
| GeneFamily | Cytochrome P450 family 4 | 6.76e-03 | 36 | 62 | 2 | 1003 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-07 | 137 | 92 | 6 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-07 | 137 | 92 | 6 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.72e-06 | 175 | 92 | 6 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.72e-06 | 175 | 92 | 6 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-06 | 187 | 92 | 6 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | Globus_pallidus-Endothelial|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.68e-06 | 189 | 92 | 6 | ad7dc9d25edd68fb624380a082c389fe7d640e7d | |
| ToppCell | proximal-Hematologic-Platelet/Megakaryocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.94e-06 | 192 | 92 | 6 | 522d1bb15edf1d6006b80289bd3baadb99584ae8 | |
| ToppCell | proximal-3-Hematologic-Platelet/Megakaryocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.94e-06 | 192 | 92 | 6 | f5f83dec37dff32a0c471cb05d23d13b0b0ad0c9 | |
| ToppCell | proximal-Hematologic-Platelet/Megakaryocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.94e-06 | 192 | 92 | 6 | 57899a905ca3e336bb7f31edc6418a2546b9891a | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.12e-06 | 194 | 92 | 6 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.12e-06 | 194 | 92 | 6 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.51e-06 | 198 | 92 | 6 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.51e-06 | 198 | 92 | 6 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.61e-06 | 199 | 92 | 6 | 41f046646fff65b7e51b63d3204f76ef32054781 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.61e-06 | 199 | 92 | 6 | ef7f7f7c861827574b120f48cf4052c563929081 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.95e-06 | 128 | 92 | 5 | 082b3dc312b033c9b21cf73499009a1dc049ee2b | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.45e-05 | 149 | 92 | 5 | 89705865e94360c1288ee98c5a6b381f3c6242b3 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-05 | 169 | 92 | 5 | 0cece9b2bb1f58e465c20ec8735a4fc3c1021f03 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-05 | 169 | 92 | 5 | 6937c46b119d4ce382fc8c2fa5925ede5ae89c81 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 173 | 92 | 5 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-05 | 173 | 92 | 5 | 176b956e71d98e8275d698b39437fc326e5fe449 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 173 | 92 | 5 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 173 | 92 | 5 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 175 | 92 | 5 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.41e-05 | 178 | 92 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.89e-05 | 183 | 92 | 5 | 6b5eef96b28911c752a8b6c0975918c4572cec38 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 184 | 92 | 5 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 184 | 92 | 5 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 4.10e-05 | 185 | 92 | 5 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 185 | 92 | 5 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.42e-05 | 188 | 92 | 5 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | Entopeduncular-Endothelial|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.42e-05 | 188 | 92 | 5 | 94774652fd42bad5012356672ffac8b6d2c22d37 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.54e-05 | 189 | 92 | 5 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.89e-05 | 192 | 92 | 5 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-05 | 192 | 92 | 5 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 192 | 92 | 5 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.89e-05 | 192 | 92 | 5 | 705ce805cb00a53793b57bcf466d0fbec590a83c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.01e-05 | 193 | 92 | 5 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.01e-05 | 193 | 92 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.01e-05 | 193 | 92 | 5 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.01e-05 | 193 | 92 | 5 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-05 | 193 | 92 | 5 | 4893b922e129711d5886bd4f3ee106e9e7065971 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-05 | 193 | 92 | 5 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.01e-05 | 193 | 92 | 5 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | droplet-Lung-nan-21m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-05 | 193 | 92 | 5 | ae35c5757a88b02f8b9f94a0af4c3396ca828cc3 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.14e-05 | 194 | 92 | 5 | e13923860a64ba9cf32df53c9f0cf4e7c321881d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-05 | 194 | 92 | 5 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.14e-05 | 194 | 92 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | droplet-Lung-1m-Endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.14e-05 | 194 | 92 | 5 | b1a25e3b36e7b7e558ef95ec22a3bdcbceae821f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.14e-05 | 194 | 92 | 5 | 5031f324628ff12a33e84cc52157be4786e0961d | |
| ToppCell | IPF-Endothelial|IPF / Disease state, Lineage and Cell class | 5.14e-05 | 194 | 92 | 5 | 9591993aa2dcba3d09a0f1ea8b8f2439c26482d6 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.14e-05 | 194 | 92 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.14e-05 | 194 | 92 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.14e-05 | 194 | 92 | 5 | fc3f81b5bdc544a69c355e482f002643e029a7b0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.14e-05 | 194 | 92 | 5 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | droplet-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.14e-05 | 194 | 92 | 5 | b49c19c33ad2e391d9367a4a2695b2fe87dd8a08 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.14e-05 | 194 | 92 | 5 | 86508dd9b9d345b6624d185048cc92b81dd11c2a | |
| ToppCell | droplet-Lung-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.14e-05 | 194 | 92 | 5 | fd4548db0f12170b636186e6af90666f7e26c0ad | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 195 | 92 | 5 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | Posterior_cortex-Endothelial|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.26e-05 | 195 | 92 | 5 | 988e3449691cc228cb55e5e30355136c97b12262 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.39e-05 | 196 | 92 | 5 | 915e4a7422058be246b54760df31e8a607310625 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 5.52e-05 | 197 | 92 | 5 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.52e-05 | 197 | 92 | 5 | 81718164c9802ee20c860ffbda7e62d5e9a76f16 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.52e-05 | 197 | 92 | 5 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.66e-05 | 198 | 92 | 5 | a1ccbf0e653b2dd665c2254920eb9b37243cc0bd | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.66e-05 | 198 | 92 | 5 | 1d30a1f73b6d6d838f49751402a29c5ef54aa81f | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.66e-05 | 198 | 92 | 5 | 5eedcc20e35adbabe268a93b748ee4566b3ffb66 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.66e-05 | 198 | 92 | 5 | 0c8ec287500c58938ecc0dbbbc5f6c7a48733fc6 | |
| ToppCell | Bronchial-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-05 | 199 | 92 | 5 | 36a230b80096455df26c2e2c8c05fd6b231508c5 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-05 | 199 | 92 | 5 | d58edc5f74970bb26d844746184e4bae7c494d6b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-05 | 199 | 92 | 5 | 6f5ef959b51eccf1ffc2e5ddf0d83c62ca2257b2 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.79e-05 | 199 | 92 | 5 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.79e-05 | 199 | 92 | 5 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-05 | 199 | 92 | 5 | 1aa99d21bf61b86df4a966dc47634044430aa39f | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-05 | 199 | 92 | 5 | 079931e7196719f22a89cfad82f452ec67219ee5 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.93e-05 | 200 | 92 | 5 | db6281b5d4032116310db379d9175d790994c99c | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.93e-05 | 200 | 92 | 5 | 2488aa12970a43a5af352e2c36c73884d73a1cc5 | |
| ToppCell | Neuronal-Inhibitory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.93e-05 | 200 | 92 | 5 | 9ff8647e2de0b538e15929dca88ebb20ff7ab043 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.93e-05 | 200 | 92 | 5 | 77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.93e-05 | 200 | 92 | 5 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | 10x5'v1-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.93e-05 | 200 | 92 | 5 | e786544cf6f891550c4be55ebb4928c92297b504 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.93e-05 | 200 | 92 | 5 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 5.93e-05 | 200 | 92 | 5 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.14e-04 | 142 | 92 | 4 | f720f13b339589fa924a42e89393e5db0b26300b | |
| ToppCell | MS-CD4-CD8_1|MS / Condition, Cell_class and T cell subcluster | 2.64e-04 | 150 | 92 | 4 | 7dc95c58b98d8c4c6c49fb1a03ec6ac24fb41f54 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8-Trm_gut_CD8|bone_marrow / Manually curated celltypes from each tissue | 2.71e-04 | 151 | 92 | 4 | 5eebdc7ad6af3cc0263e4d8c3516818305ac38f2 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.99e-04 | 155 | 92 | 4 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | Striatum-Neuronal-Inhibitory|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.14e-04 | 157 | 92 | 4 | c41ff3fe9de7187575114febfe9bd8733366fb8a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Neutrophil|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-04 | 160 | 92 | 4 | 7af3fbe555ff2eb1272381411617646e9e8c0440 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 3.54e-04 | 162 | 92 | 4 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-04 | 163 | 92 | 4 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.62e-04 | 163 | 92 | 4 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-04 | 163 | 92 | 4 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-04 | 163 | 92 | 4 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 3.79e-04 | 165 | 92 | 4 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 3.79e-04 | 165 | 92 | 4 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-7|TCGA-Kidney / Sample_Type by Project: Shred V9 | 3.88e-04 | 166 | 92 | 4 | b545de32578047c9ca422354b8992f2d9c9e1cc7 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.97e-04 | 167 | 92 | 4 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | P28|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.06e-04 | 168 | 92 | 4 | 4ee59a6147bbe7e4a03cc2d6fe9d6c10b18a3a06 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.06e-04 | 168 | 92 | 4 | 32e4d82efaccf336d347e4063253c3635a3ec672 | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Up 200; 35uM; PC3; HT_HG-U133A | SPTBN5 ZFP36L1 ZFP36L2 ZNF423 TSGA10 FRS3 ACVRL1 CPLANE1 ZNF467 | 1.06e-07 | 197 | 92 | 9 | 4618_UP |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.36e-06 | 197 | 92 | 8 | 3837_DN | |
| Disease | double outlet right ventricle (implicated_via_orthology) | 2.40e-05 | 3 | 84 | 2 | DOID:6406 (implicated_via_orthology) | |
| Disease | systolic blood pressure, alcohol drinking | 3.33e-05 | 128 | 84 | 5 | EFO_0004329, EFO_0006335 | |
| Disease | dextro-looped transposition of the great arteries (implicated_via_orthology) | 4.79e-05 | 4 | 84 | 2 | DOID:0060770 (implicated_via_orthology) | |
| Disease | right atrial isomerism (implicated_via_orthology) | 4.79e-05 | 4 | 84 | 2 | DOID:0060856 (implicated_via_orthology) | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 2.85e-04 | 315 | 84 | 6 | EFO_0004574, EFO_0004612 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 2.85e-04 | 315 | 84 | 6 | EFO_0004612, EFO_0008591 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 3.15e-04 | 321 | 84 | 6 | EFO_0004612, EFO_0004639 | |
| Disease | diastolic blood pressure, alcohol drinking | 3.66e-04 | 118 | 84 | 4 | EFO_0004329, EFO_0006336 | |
| Disease | visceral heterotaxy (is_implicated_in) | 5.19e-04 | 12 | 84 | 2 | DOID:0050545 (is_implicated_in) | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 5.25e-04 | 55 | 84 | 3 | EFO_0022288 | |
| Disease | free cholesterol in HDL measurement | 7.11e-04 | 61 | 84 | 3 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 7.11e-04 | 61 | 84 | 3 | EFO_0022293 | |
| Disease | total lipids in HDL measurement | 7.81e-04 | 63 | 84 | 3 | EFO_0022307 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 9.72e-04 | 153 | 84 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | phospholipids in large HDL measurement | 1.20e-03 | 73 | 84 | 3 | EFO_0022190 | |
| Disease | total lipids in large HDL | 1.25e-03 | 74 | 84 | 3 | EFO_0022189 | |
| Disease | high density lipoprotein particle size measurement | 1.43e-03 | 170 | 84 | 4 | EFO_0008592 | |
| Disease | cholesterol in large HDL measurement | 1.56e-03 | 80 | 84 | 3 | EFO_0021900 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.56e-03 | 80 | 84 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.76e-03 | 303 | 84 | 5 | EFO_0004612, EFO_0020945 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 1.86e-03 | 307 | 84 | 5 | EFO_0004612, EFO_0020946 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 2.00e-03 | 312 | 84 | 5 | EFO_0004612, EFO_0010351 | |
| Disease | waist-hip ratio | ADAMTS10 HHIP ADRB1 KLF6 ZNF423 KIAA1328 ZNF407 DOCK6 TRIM7 STC1 | 2.51e-03 | 1226 | 84 | 10 | EFO_0004343 |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 2.55e-03 | 330 | 84 | 5 | EFO_0004529, EFO_0004612 | |
| Disease | mean arterial pressure, alcohol drinking | 2.79e-03 | 98 | 84 | 3 | EFO_0004329, EFO_0006340 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LHRALGQARDHCRPR | 221 | P24298 | |
| RHATHGDRPRASGCL | 401 | P08588 | |
| DAALSSHRHPGCAQR | 6 | A0FGR8 | |
| HNVSRLHRLPRDCQE | 176 | Q9BY76 | |
| GRARSREEENEHHGP | 391 | Q12774 | |
| GRARSREEENEHHGP | 391 | A5YM69 | |
| RASFRDGDPVHRHRQ | 36 | O75843 | |
| RPHRSCRDPAVHQAL | 51 | Q96NS5 | |
| EDAPQCHEHFSRITR | 566 | A5YM72 | |
| RHPQEHRGCGNLHRE | 61 | P37023 | |
| HDQRRSECGALEHGA | 116 | P0CG36 | |
| RAHRHQDPSKECAGA | 936 | Q00975 | |
| HDQRRSECGALEHGA | 116 | P0CG37 | |
| RHPHLDTACGVRDEK | 186 | Q9H324 | |
| DDRDSHCRRPKFEGH | 251 | Q9Y5S8 | |
| RLRAHDPDQGSHGRL | 706 | Q96JQ0 | |
| PRRHSHEDQEFRCRS | 66 | A1A4G5 | |
| GHCHAPDEQGLEARR | 171 | Q4VC44 | |
| RHSDRQDCRSPHEVF | 96 | Q86X51 | |
| QAPTAGRDCHHRADP | 21 | Q14432 | |
| GRDCHHRADPASPRD | 26 | Q14432 | |
| RDPINHRRAALDHSC | 896 | Q5T7B8 | |
| GPRLRCLHHDQGLTE | 26 | Q9Y6Z4 | |
| CGHRLAADRVHDSHP | 306 | Q86T90 | |
| ACDRARVFLHSDEHP | 396 | Q6ZV29 | |
| NPHCLHRRPADESNL | 696 | Q8ND30 | |
| HELCPEERHHIGDRS | 581 | Q9Y2A7 | |
| EERHHIGDRSLSLCN | 586 | Q9Y2A7 | |
| DRLEHLRRQCGPHVS | 336 | Q9H4Z3 | |
| HRSLEAAQDARGHCP | 816 | Q96HP0 | |
| ENAREPRKNSPHCHE | 2126 | Q9H799 | |
| RRRPDSCHAFHPEEN | 1091 | Q7Z3S7 | |
| PASEDDHRRGRHCLQ | 196 | O43559 | |
| PDGQRFRRACHLVHD | 251 | Q9HBI6 | |
| LVDLERRSHHPESGC | 91 | Q5TA50 | |
| REQHGRDESVHRCEP | 51 | Q86WU2 | |
| HRDLAARNCLVGENH | 361 | P00519 | |
| RRPSHCELDLAEGHQ | 131 | P12980 | |
| ACRSDAHPELVRRHL | 631 | Q63ZY3 | |
| NQARPHCRLVALDGH | 576 | Q5VTJ3 | |
| HRAPRDLDESSGVRH | 136 | Q9P0J7 | |
| FHRRRHQSPDCCESE | 81 | O14633 | |
| FHRRRHQSPDCCESE | 81 | Q5TA81 | |
| FHRRRHQSPDCCESE | 81 | Q5TA82 | |
| PHGRRFLRACQVAHD | 241 | P13584 | |
| QGDFHLLDHRGRARC | 101 | O43819 | |
| RADSHRNSDVRHAPA | 66 | Q5FWE3 | |
| RENPPHDSRRDCHGK | 796 | Q92613 | |
| GRDRCLHESKGRAHP | 261 | O14792 | |
| HRAVRALCDHTAARP | 846 | Q9BVN2 | |
| HCHRNLGLIFDRGDP | 66 | Q8TDW5 | |
| RCVPSLHHRALDAEE | 31 | Q9Y5J6 | |
| DPAERARHNCYRELH | 151 | Q2KHN1 | |
| NPERHDRRLNHFRVC | 101 | A6NL82 | |
| TRDCPHRGHDDIVNF | 321 | Q6IQ23 | |
| HHCPVKNRGIRDRDS | 1386 | Q6ZUB1 | |
| ERAAQRGHRAEGCHD | 66 | Q5T8A7 | |
| RGHRAEGCHDARPAA | 71 | Q5T8A7 | |
| ADHSQGRAEPGHERR | 621 | Q5T8A7 | |
| SDPDVERCLRAHRND | 61 | O14684 | |
| AHGLHDPGRCAVDRH | 426 | Q96QV1 | |
| CQRSPEAAHGLRHRQ | 2431 | Q9NRC6 | |
| HCAQTHPRADFNRRR | 201 | P52823 | |
| EECARAGFPRAHRHK | 586 | O75153 | |
| VNRHGPEADRHLLRC | 36 | A5YKK6 | |
| RTENHGAPACHRLKE | 126 | Q9NUW8 | |
| PRCHFIHNAEERRAL | 171 | Q07352 | |
| QCHRSASLDHRGLRG | 161 | Q6ZTA4 | |
| TDLALNGRHGDSHCR | 66 | Q8TCW7 | |
| HRRVHTGARPHACRD | 236 | Q6ZNH5 | |
| VCDRAREHREHAVLP | 151 | Q9C029 | |
| RLRQEQEHHGAAPTC | 876 | Q76I76 | |
| QPGEEERRESHHLRS | 816 | O94991 | |
| TAELAEHRCHPVERG | 671 | Q9BQI7 | |
| LPEIHGCGERARAHA | 926 | P38935 | |
| QCPDRLGHDATEDAR | 356 | Q96IC2 | |
| NCRDLEGRHSTPLHF | 676 | O95271 | |
| LRHRRSHQGERPHAC | 271 | Q499Z4 | |
| RPGAHASRDECRIHL | 211 | Q8IV45 | |
| LRHCIREGGHDVPSN | 221 | Q9BQ87 | |
| ARGRCAPDHFQEDHL | 3601 | Q96JG9 | |
| AHHRSPDRGLDRSLE | 676 | Q9BZW7 | |
| ARHHCPEARAAQDCR | 226 | Q9NXH8 | |
| ERERDRHSPFGQRHL | 1446 | Q9ULD9 | |
| EHEGRPLCENHFHAR | 386 | O43294 | |
| HRSSRCESHQDLLPD | 1211 | Q9ULL1 | |
| DLTDHRAHRCPGDGD | 81 | Q2M1K9 | |
| HRHLCPVTLDGERSA | 1246 | Q9C0G0 | |
| RCHFIHNADERRPAP | 211 | P47974 | |
| RHLRSHSAERPFECE | 426 | Q9BR84 | |
| HCAFQGRDRADLLEH | 471 | Q9NTW7 | |
| HQRSHRGERPFPCSE | 206 | Q7Z7K2 | |
| CGRAFRERPALLHHQ | 486 | Q6AW86 | |
| NRHHRIHTGERPFEC | 486 | Q8NB42 | |
| ASPDGRRRVHRCHFN | 191 | Q99612 | |
| HRRVHSGERPFACAE | 531 | P28698 | |
| LPELGHDCRAQNRTH | 341 | O15399 |